Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$41.26 - $51.35 $31,811 - $39,590
771 New
771 $34,000
Q1 2022

May 16, 2022

SELL
$44.58 - $52.6 $53,852 - $63,540
-1,208 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$45.82 - $56.9 $55,350 - $68,735
1,208 New
1,208 $62,000
Q2 2020

Aug 14, 2020

SELL
$43.24 - $55.02 $8,042 - $10,233
-186 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$34.37 - $60.07 $6,392 - $11,173
186 New
186 $9,000
Q1 2019

May 15, 2019

SELL
$38.66 - $51.82 $1,275 - $1,710
-33 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$36.72 - $67.73 $1,211 - $2,235
33 New
33 $1,000

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $6.51M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.